Collaboration in the Fight Against Fentanyl

Collaboration in the Fight Against Fentanyl

← Back to Series 

This webinar will identify partnerships and innovative efforts in the whole of government approach to identify and interdict fentanyl analogs, as well as to heighten awareness and strengthen legal mechanisms for dealing with the illicit fentanyl crisis.

Illicitly manufactured fentanyl’s intrusion into drug markets in the United States is significantly contributing to an opioid epidemic that is claiming thousands of lives each year. Illicit fentanyl and its analogs are imported predominantly from China, with Mexico and Canada serving as trans-shipment points. Fentanyl is illegally ordered via the dark web and the open internet and is delivered by private express shippers or the United States Postal Service to businesses and residences across the U.S.

This presentation will review the prevalence, modes of importation, and availability of fentanyl in the U.S. illicit market based on de-identified drug seizure and post-mortem findings and unclassified law enforcement data. Challenges to identification of fentanyl in the law enforcement and medicolegal death investigation communities will be discussed, as will federal legal standards relating to fentanyl identifications and prosecutions. Using and sharing information on new fentanyl analogs, whether obtained through federal, state, local, or private testing of seized drugs and postmortem toxicology is essential to get a baseline understanding of the scope of the problem and the identification of new fentanyl analogs and novel psychoactive substances.

Funding for this Forensic Technology Center of Excellence event has been provided by the National Institute of Justice.

A certificate of completion is available for all who register and attend this webinar.

M.J. Mendendez
Victor Weedn

Register Here

Please contact us at for any questions.

Each of our webinars is archived within about two weeks of the live date and will be posted on our website. Please subscribe to our newsletter for notifications.